BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 809241)

  • 1. Moderate hypertension: treatment with guanethidine and methyldopa.
    Dunn MI; Freeman J
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):285-94. PubMed ID: 809241
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled trial of guanethidine and methyldopa in moderate hypertension.
    Tarpley EL
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1187-96. PubMed ID: 4214653
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of guanethidine and methyldopa in essential hypertension: a controlled study.
    Glazer N
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):249-56. PubMed ID: 805019
    [No Abstract]   [Full Text] [Related]  

  • 4. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Considerations on ambulatory therapy in a group of hypertensive patients].
    Repetto S; Rezzonico A; Gervasini N
    Minerva Med; 1969 Jun; 60(51):2550-4. PubMed ID: 5792420
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Office management of hypertension.
    Moser M
    Am Fam Physician; 1974 Sep; 10(3):152-8. PubMed ID: 4414894
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of guanethidine and hydrochlorothiazide in the treatment of arterial hypertension with and without renal failure.
    Muiesan G; Motolese M; Petz E; Todisco T
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):489-94. PubMed ID: 4887948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of arterial hypertension with an association of drugs in low dosage].
    Romboli L; Sullo B; Seppia M
    Minerva Cardioangiol; 1975 Oct; 23(10):675-80. PubMed ID: 1232573
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical trial of alpha-methyldopa (Aldomet) and hydrochlorthiazide (Dichlotride) alone and in combination in hypertension.
    Vaidya PM; Munshi CP; Sawkar LA; Parikh HM; Gulati OD
    Indian J Physiol Pharmacol; 1971 Jan; 15(1):35-41. PubMed ID: 4941549
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems of essential hypertension].
    Latotzki H
    Z Arztl Fortbild (Jena); 1965 Nov; 59(22):1196-9. PubMed ID: 5888328
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of guanethidine and hydrochlorothiazide in the long-term treatment of essential hypertension.
    Brown WJ; Brown FK
    Curr Ther Res Clin Exp; 1975 Jun; 17(6):544-54. PubMed ID: 808377
    [No Abstract]   [Full Text] [Related]  

  • 14. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.
    Oates JA; Seligmann AW; Clark MA; Rousseau P; Lee RE
    N Engl J Med; 1965 Sep; 273(14):729-34. PubMed ID: 5317954
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of essential and nephrogenic hypertension using alpha-methyldopa and alpha-methyldopa+hydrochlorothiazide. Comparative study].
    Sales EJ; Villa JJ; Mendez MA
    Prensa Med Argent; 1971 Jun; 58(14):741-8. PubMed ID: 5091433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of hypotensive agent: Esimil].
    Warembourg H; Stalnikiewicz G
    Lille Med; 1970; 15():Suppl 5:993-8. PubMed ID: 4921128
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
    Prichard BN; Gillam PM; Graham BR
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):131-40. PubMed ID: 4924319
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guanethidine-hydrochlorothiazide combination in the treatment of arterial hypertension].
    Trompetto G
    Clin Ter; 1974 Dec; 71(6):563-71. PubMed ID: 4448053
    [No Abstract]   [Full Text] [Related]  

  • 19. Double blind evaluation of indoramin and methyldopa in thiazide treated hypertensive patients.
    Yajnik VH; Patel SC
    Indian Heart J; 1978; 30(1):51-6. PubMed ID: 359454
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multicenter study of the efficacy of 3 antihypertensive regimens: captopril + hydrochlorothiazide, oxprenolol + hydrochlorothiazide, and alphamethyldopa + hydrochlorothiazide].
    Ocón J; Oliván J; Garrido Peralta M; Ruilope L; Rodicio JL; Seco Vasco J; Rodríguez Alvarez J; Gras X
    Med Clin (Barc); 1985 Nov; 85(15):617-21. PubMed ID: 3908851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.